The Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard was launched on 9 May 2024. See the expert panel discuss key challenges and best practice to ensure appropriate use of psychotropic medicines in people with cognitive disability or impairment, including informed consent, assessment, non-medication strategies and follow-up care when medicines are considered necessary.
For more information, visit www.safetyandquality.gov.au/psychotropics-ccs